Camp4 Therapeutics Corp

CAMP · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.2B · 48 employees
32
SEC Filings
$4.39
Close 2026-05-29
48
Employees

Business Summary

PART I Overview We are a clinical-stage biopharmaceutical company pioneering the discovery and development of a new class of RNA-targeting therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases. Our lead product candidate, CMP-002, has the potential to be the first disease-modifying therapy for the treatment of synaptic Ras GTPase activating protein 1 (SYNGAP1)-related disorder, or SYNGAP1, a severe developmental...

Latest Stock Quote

CAMP 2026-05-29 $4.39 O:$4.5 H:$4.5 L:$4.2701 Vol:0.1M VWAP:$4.3952
origin leaf: 631a3bba9ca8e25768f1044aaa3d3c3b8d9dfa0bcd47f0d99d4de114bbf2fbba

Next Earnings

Q2 FY2026 — expected 2026-09-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001736730-26-000016EDGAR101K words
2025-03-272024-12-310001736730-25-000022EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001736730-25-000094EDGAR23K words
2025-08-142025-06-300001736730-25-000070EDGAR
2025-05-132025-03-310001736730-25-000039EDGAR
2024-11-212024-09-300001410578-24-002045EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-240001736730-26-000021EDGAR1K words
2026-03-050001736730-26-000015EDGAR
2026-01-090001736730-26-000004EDGAR
2025-12-230001736730-25-000116EDGAR
2025-12-180001628280-25-058009EDGAR
2025-12-180001736730-25-000111EDGAR
2025-11-060001736730-25-000092EDGAR
2025-10-010001736730-25-000074EDGAR
2025-09-100001736730-25-000072EDGAR
2025-08-140001736730-25-000068EDGAR

32 total filings indexed. 16 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001736730
TickerCAMP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.camp4tx.com
Listed2024-10-11

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 8fdce5293afe6cdd4330123b9104d7dcc0b3b91aa12f5625c78a99b840b84d79
parent: 2396e1b29f83f57d3ef3e00393641e13fdf13d701a7258c984e4712a24c5214d
content hash: f130360a921b73adc6ad41899be70f8d9398cda0ce3c762e5512542fa0e0a7f2
signed: 2026-06-02T19:00:33.653Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf